AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
Oncology Grand Rounds, Summaries from ESMO 2024 | October 11th
Events
AGORA Tumor Microenvironment Journal Club | October 18th
Events
You are invited: AGORA Apéro | October 31st
Events
LabLinks: Tumor immunology and immunotherapy | November 11&12th
Events
SAVE THE DATE – 1st Symposium on AI Driven-Advances in Clinical and Translational Medicine | November 13th
Events
3RCC event | November 20th
Latest publications
Crosstalk of T cells within the ovarian cancer microenvironment.
Chap BS, Rayroux N, Grimm AJ, Ghisoni E, Dangaj Laniti D
Trends in cancer – 2024 Sep 27
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion.
Fiorenza S, Zheng Y, Purushe J, (…), Yang JYH, Henikoff S, Turtle CJ
Nature communications – 2024 Sep 27
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission.
Bai Z, Feng B, McClory SE, (…), Melenhorst JJ, Grupp SA, Fan R
Nature – 2024 Sep 25
The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8(+) T cells against cancer.
Feng B, Bai Z, Zhou X, (…), Fan R, Guo Y, Tang L
Nature – 2024 Sep 25
PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma.
Martínez Bedoya D, Marinari E, Davanture S, (…), Walker PR, Dutoit V, Migliorini D
Cancer immunology research – 2024 Sep 13
